3 ASX Growth Stocks Positioned for a Strong 2026
Every few years, the market quietly reshuffles its priorities. Businesses that were once seen as niche players begin to show scale, while others prove their staying power by turning ideas into repeatable revenue. When investors think about 2026 and beyond, the focus naturally shifts to companies that are not dependent on short cycles, but are building products and services the world continues to need.
On the ASX, three growth-oriented companies often appear in long-term discussions for this very reason. Pro Medicus, Catapult Sports, and Xero operate in very different industries, yet they share a common foundation. Each is built around technology, recurring revenue, and global demand. More importantly, each has already demonstrated execution, not just ambition.
Let’s explore what places these three ASX growth stocks in a strong position looking ahead.
Pro Medicus: Quietly Powering Digital Healthcare
Healthcare systems around the world are under pressure to do more with less. Faster diagnosis, remote access, and efficient workflows are no longer optional. This is where Pro Medicus fits in.
The company develops enterprise imaging software that allows hospitals and radiology groups to store, view, and analyse medical images through its Visage platform. This might sound technical, but its impact is simple. Doctors get faster access to scans, hospitals reduce bottlenecks, and patient care becomes more efficient.
From a business perspective, Pro Medicus has built an enviable track record. The company has consistently reported strong revenue and profit growth over recent years. In the 2025 financial year, it achieved record revenue and earnings, supported by major multi year contracts in the United States, which is the largest healthcare market in the world.
One key data point investors often note is the nature of these contracts. Many run for five to seven years and are signed well before full revenue flows through the income statement. This creates a backlog of contracted revenue that supports visibility into future earnings. The company also operates with no debt and a strong cash balance, giving it flexibility to invest in research, infrastructure, or shareholder returns.
Looking toward 2026, the strength of Pro Medicus lies in execution rather than expansion for expansion’s sake. As more signed contracts transition into active usage, revenue continues to compound without needing a proportional increase in costs. In a world where digital healthcare adoption continues to rise, Pro Medicus remains deeply aligned with how hospitals are evolving.
Catapult Sports: Data Becomes a Competitive Edge
Sports have always been about talent and training. Today, data plays an equally important role. Catapult Sports sits at the intersection of performance, technology, and analytics.
The company provides wearable devices and software platforms that track athlete movement, workload, and recovery. These insights help teams reduce injury risk, improve performance, and manage players across long seasons. Catapult’s customer base includes thousands of professional teams, national sporting bodies, and universities across more than 40 countries.
One of the most important data points in Catapult’s business is annualised contract value. This metric reflects recurring revenue from subscriptions and long term agreements. Over recent years, Catapult has reported steady growth in this figure, along with high customer retention. Once teams integrate Catapult’s systems into training routines, switching costs become meaningful.
Financially, Catapult has moved through an investment-heavy phase. The company spent years building products, expanding globally, and acquiring complementary businesses. Recent results show a shift toward operating discipline. Losses have narrowed, margins have improved, and cash flow trends have strengthened.
By 2026, the story investors watch closely is scale. As revenues grow while fixed costs stabilise, the business model begins to show operating leverage. With sports analytics becoming standard rather than experimental, Catapult’s position as a category leader places it well for sustainable growth driven by recurring subscriptions.
Xero: More Than Just Accounting Software
Xero is one of the most recognisable technology companies on the ASX, and for good reason. What started as cloud based accounting software has evolved into a central operating system for small and medium sized businesses.
Xero serves millions of subscribers globally, with strong footholds in Australia, New Zealand, the United Kingdom, and growing presence in North America. Its platform handles invoicing, payroll, tax, bank feeds, and reporting, all in real time. For many businesses, Xero is one of the first tools they log into each day.
From a data standpoint, subscription numbers continue to grow steadily, while average revenue per user has increased through add on services and ecosystem partnerships. The company has also improved profitability metrics in recent periods, showing that scale is translating into stronger financial outcomes.
What positions Xero well for 2026 is its ecosystem strategy. Rather than remaining a standalone accounting product, Xero integrates with hundreds of third party apps across payments, inventory, lending, and workforce management. This makes the platform stickier and harder to replace.
While competition exists in cloud accounting, switching costs are high once financial data, payroll, and compliance systems are embedded. As regulatory complexity and digital reporting requirements increase globally, cloud native platforms like Xero become even more relevant.
What These Three Companies Have in Common
Despite operating in healthcare, sports, and business software, Pro Medicus, Catapult, and Xero share several traits that support long term growth.
First, all three rely on recurring revenue. Whether through long term contracts or subscriptions, this creates predictability and resilience.
Second, their markets are global. Revenue growth is not limited to Australia, allowing scale far beyond the local economy.
Third, technology is central to their value. Each company solves real problems using software and data, not one off products.
Finally, they are aligned with structural trends. Digital healthcare, performance analytics, and cloud business tools are long term shifts, not passing phases.
Looking Beyond the Short Term
Thinking about 2026 means focusing less on quarterly noise and more on business direction. Pro Medicus, Catapult Sports, and Xero represent companies that have already proven demand for their products and are now focused on scaling efficiently.
Their growth stories are not built on promises alone. They are supported by contracts, subscribers, and data that point toward durable relevance. For investors who value patience and long term thinking, these three ASX growth stocks continue to stand out for the years ahead.
Disclaimer:
General Financial Product Advice and Regulatory Framework: Pristine Gaze Pty Ltd (ABN 66 680 815 678, ACN 680 815 678) operates as Corporate Authorised Representative (CAR No. 001312049) of Alpha Securities Pty Ltd (AFSL 330757), which is licensed and regulated by the Australian Securities and Investments Commission under the Corporations Act 2001 (Cth). This report contains general financial product advice only and has been prepared without consideration of your personal objectives, financial situation, specific needs, circumstances, or investment experience. The information is not tailored to individual circumstances and may not be suitable for your particular situation. Before acting on any information contained herein, you should carefully consider its appropriateness having regard to your personal objectives, financial situation, and needs, and consider seeking personal financial advice from a qualified financial adviser who can assess your individual circumstances and provide tailored recommendations.
Investment Risks and Market Warnings: All investments carry significant risk, and different investment strategies may carry varying levels of risk exposure including total loss of invested capital. The value of investments and income derived from them can fluctuate significantly due to market conditions, economic factors, company-specific events, regulatory changes, commodity price volatility, currency fluctuations, interest rate movements, and other factors beyond our control. Securities markets are subject to market risk from general economic conditions and investor sentiment, liquidity risk affecting the ability to buy or sell securities at desired prices, credit risk from issuer default or deterioration, operational risk from inadequate internal processes, sector-specific risks including industry regulatory changes, technology obsolescence, management changes, competitive pressures, supply chain disruptions, and mining-specific risks including resource estimation uncertainty, operational hazards, environmental compliance, permitting delays, commodity price cycles, geopolitical factors affecting mining operations, and exploration risks. Small-cap and speculative mining stocks carry additional risks including limited liquidity, higher volatility, dependence on key personnel, limited operating history, uncertain cash flows, and potential failure to achieve commercial production.
Information Accuracy and Limitations: While we endeavour to ensure information accuracy and reliability, we make no representations or warranties (express or implied) regarding the accuracy, reliability, completeness, timeliness, or suitability of information provided, except where liability cannot be excluded under applicable law. This report may include information from third-party sources including company announcements, regulatory filings, research reports, market data providers, financial news services, and publicly available information, which we do not independently verify and for which we assume no responsibility. Past performance, examples, historical data, or projections are not indicative of future results, and no guarantee of future returns is provided or implied. To the maximum extent permitted by law, Pristine Gaze Pty Ltd and Alpha Securities Pty Ltd, together with their respective directors, officers, employees, representatives, and related entities, exclude all liability for any errors, omissions, inaccuracies, loss or damage (including direct, indirect, consequential, or special damages) arising from reliance on information provided, investment decisions made based on this report, market losses, opportunity costs, and technical issues or system failures.
